Biopharmaceutical research

SCHERING-PLOUGH is an innovation-driven, science-centered global healthcare company.

Through its own biopharmaceutical research and collaborations with partners, Schering- Plough creates therapies that help save and improve lives around the world. The company applies its research and development platform to human prescription and consumer products as well as to animal health products. In November 2007, Schering- Plough acquired Organon BioSciences, with its Organon human health and Intervet animal health businesses, marking a pivotal step in the company’s ongoing transformation.

Latest Issues

EBME Expo 2025

Coventry Building Society Arena, UK
25th - 26th June 2025

AfPP Annual National Conference

University of Warwick
8th - 9th August 2025

Clinical Engineering Conference

Stansted Radisson Blu
23rd September 2025

Infection Prevention 2025

Brighton Centre, UK
29th - 30th September 2025